Clinical Trial Update: Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the electrophysiological effects of guanfacine extended-release in attention-deficit/hyperactivity disorder. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Intuniv (guanfacine hydrochloride)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2012-09-03